In line with the findings in the present study, it has been shown that APOE3 and APOE4 carriers develop AD through different metabolic pathways72; therefore, it will be critical for future studies to identify precision nutrition approaches that tailored to different APOE variants to mitigate AD risk. Here, APOE is linked to Alzheimer disease.